Published in BMC Med Res Methodol on April 25, 2005
Bone-patellar tendon-bone autografts versus hamstring autografts for reconstruction of anterior cruciate ligament: meta-analysis. BMJ (2006) 3.03
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ (2010) 2.19
Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies. Br J Gen Pract (2013) 1.75
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51
A model for dissemination and independent analysis of industry data. JAMA (2011) 1.35
Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med Res Methodol (2010) 1.21
Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis. Gastric Cancer (2011) 1.19
Thinking big: large-scale collaborative research in observational epidemiology. Eur J Epidemiol (2009) 1.15
A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci (2009) 1.13
Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases. Pharmacoepidemiol Drug Saf (2010) 1.10
Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care (2008) 1.10
Meta-analysis: pitfalls and hints. Heart Lung Vessel (2013) 1.06
Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.04
Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention. Prev Sci (2013) 0.97
Mobile phone text messages for improving adherence to antiretroviral therapy (ART): a protocol for an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 0.96
Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Synth Methods (2015) 0.93
TLR1, 2, 4, 6 and 9 Variants Associated with Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.93
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol (2013) 0.91
Gene-gene and gene-environment interactions in meta-analysis of genetic association studies. PLoS One (2015) 0.87
Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis. BMC Med (2015) 0.86
The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev (2015) 0.85
Survey finds that most meta-analysts do not attempt to collect individual patient data. J Clin Epidemiol (2012) 0.83
Maternal alcohol binge-drinking in the first trimester and the risk of orofacial clefts in offspring: a large population-based pooling study. Eur J Epidemiol (2016) 0.80
Distribution and epidemiological characteristics of published individual patient data meta-analyses. PLoS One (2014) 0.79
When is good, good enough? Methodological pragmatism for sustainable guideline development. Implement Sci (2015) 0.78
Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. Cancer Invest (2009) 0.77
Epistasis Test in Meta-Analysis: A Multi-Parameter Markov Chain Monte Carlo Model for Consistency of Evidence. PLoS One (2016) 0.76
Comparing the Overall Result and Interaction in Aggregate Data Meta-Analysis and Individual Patient Data Meta-Analysis. Medicine (Baltimore) (2016) 0.76
Capturing Public Opinion on Public Health Topics: A Comparison of Experiences from a Systematic Review, Focus Group Study, and Analysis of Online, User-Generated Content. Front Public Health (2015) 0.76
Types of studies and research design. Indian J Anaesth (2016) 0.75
STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease. Alzheimers Dement (Amst) (2016) 0.75
Dose-response meta-analysis of differences in means. BMC Med Res Methodol (2016) 0.75
The Covariance Adjustment Approaches for Combining Incomparable Cox Regressions Caused by Unbalanced Covariates Adjustment: A Multivariate Meta-Analysis Study. Comput Math Methods Med (2015) 0.75
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings. Curr Neuropharmacol (2015) 0.75
Considerations in Understanding the Coronary Blood Flow- Left Ventricular Mass Relationship in Patients with Hypertension. Curr Cardiol Rev (2017) 0.75
Challenges and Opportunities for Exploring Patient-Level Data. Biomed Res Int (2015) 0.75
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med (1998) 19.07
Meta-analysis of the literature or of individual patient data: is there a difference? Lancet (1993) 6.16
To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof (2002) 3.11
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49
Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. Am J Epidemiol (1997) 2.19
Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics (1998) 2.11
A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. JAMA (1995) 2.02
An assessment of methods to combine published survival curves. Med Decis Making (2000) 1.47
Meta-analyses based on abstracted data: a step in the right direction, but only a first step. J Clin Oncol (2004) 1.30
On the equivalence of meta-analysis using literature and using individual patient data. Biometrics (1999) 1.24
Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. J Clin Epidemiol (1999) 1.17
From science to practice. Meta-analyses using individual patient data are needed. JAMA (1995) 1.09
Systematic reviews with individual patient data meta-analysis to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol (2003) 1.06
Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data. J Clin Epidemiol (2001) 0.97
Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. Control Clin Trials (2001) 0.96
Is there bias in the publication of individual patient data meta-analyses? Int J Technol Assess Health Care (2000) 0.88
A comparison of the results of checked versus unchecked individual patient data meta-analyses. Int J Technol Assess Health Care (2002) 0.83
The role of meta-analyses in assessing cancer treatments. Eur J Cancer (2000) 0.83
Meta-analysis of published studies or meta-analysis of individual data? Caesarean section in HIV-positive women as a study case. Public Health (2003) 0.81
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol (2007) 5.36
Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer (2007) 3.27
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.11
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies. Cancer (2007) 2.03
Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol (2006) 2.03
Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med (2002) 1.69
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res (2010) 1.66
Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw (2008) 1.65
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond. J Clin Oncol (2012) 1.37
Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. J Clin Oncol (2010) 1.36
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer (2010) 1.34
Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis. Clin Breast Cancer (2006) 1.04
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study. Cancer Med (2014) 1.03
Filgrastim in patients with neutropenia: potential effects on quality of life. Drugs (2002) 1.02
Epidemiology of febrile neutropenia. Support Cancer Ther (2003) 0.94
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy. J Natl Cancer Inst (2011) 0.89
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways. Breast Cancer Res Treat (2011) 0.86
Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines. Thromb Res (2010) 0.85
A primer in prognostic and predictive models: development and validation of neutropenia risk models. Support Cancer Ther (2005) 0.83
Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients. Curr Opin Hematol (2002) 0.78
Cancer and thrombosis: back to the future renewed interest in an old problem. Cancer Invest (2009) 0.78
Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective. Pharmacoeconomics (2007) 0.77
Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding. J Natl Cancer Inst (2009) 0.75
Cost effectiveness of myeloid growth factors in cancer chemotherapy. Curr Hematol Rep (2003) 0.75
Moving beyond febrile neutropenia. Support Cancer Ther (2005) 0.75
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial. Thromb Haemost (2017) 0.75
Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome. Cancer Treat Res (2011) 0.75